Varex Imaging $VREX Shares Bought by Legato Capital Management LLC

Legato Capital Management LLC grew its stake in shares of Varex Imaging (NASDAQ:VREXFree Report) by 889.9% during the fourth quarter, HoldingsChannel reports. The firm owned 99,810 shares of the company’s stock after buying an additional 89,727 shares during the period. Legato Capital Management LLC’s holdings in Varex Imaging were worth $1,163,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently modified their holdings of VREX. LSV Asset Management lifted its stake in shares of Varex Imaging by 210.7% during the fourth quarter. LSV Asset Management now owns 1,244,329 shares of the company’s stock worth $14,496,000 after purchasing an additional 843,805 shares in the last quarter. Millennium Management LLC lifted its stake in shares of Varex Imaging by 119.8% during the third quarter. Millennium Management LLC now owns 913,169 shares of the company’s stock worth $11,323,000 after purchasing an additional 497,650 shares in the last quarter. Qube Research & Technologies Ltd lifted its stake in shares of Varex Imaging by 2,514.9% during the second quarter. Qube Research & Technologies Ltd now owns 318,127 shares of the company’s stock worth $2,758,000 after purchasing an additional 305,961 shares in the last quarter. Deerfield Management Company L.P. acquired a new position in shares of Varex Imaging during the third quarter worth about $3,537,000. Finally, Assenagon Asset Management S.A. lifted its stake in shares of Varex Imaging by 79.9% during the fourth quarter. Assenagon Asset Management S.A. now owns 532,748 shares of the company’s stock worth $6,207,000 after purchasing an additional 236,620 shares in the last quarter.

Varex Imaging Stock Performance

NASDAQ:VREX opened at $10.07 on Monday. The company has a debt-to-equity ratio of 0.67, a quick ratio of 1.43 and a current ratio of 3.20. Varex Imaging has a one year low of $6.76 and a one year high of $14.56. The business’s 50-day simple moving average is $10.97 and its 200 day simple moving average is $12.01. The stock has a market cap of $423.95 million, a price-to-earnings ratio of -5.04 and a beta of 0.96.

Varex Imaging (NASDAQ:VREXGet Free Report) last released its quarterly earnings results on Thursday, May 7th. The company reported $0.21 EPS for the quarter, missing the consensus estimate of $0.22 by ($0.01). Varex Imaging had a positive return on equity of 8.19% and a negative net margin of 9.64%.The business had revenue of $216.00 million during the quarter, compared to analyst estimates of $216.92 million. Varex Imaging has set its Q3 2026 guidance at 0.150-0.300 EPS. As a group, sell-side analysts predict that Varex Imaging will post 0.93 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

A number of research analysts have commented on VREX shares. Weiss Ratings restated a “sell (d-)” rating on shares of Varex Imaging in a research note on Friday, March 27th. Zacks Research upgraded Varex Imaging from a “hold” rating to a “strong-buy” rating in a research note on Monday, April 13th. B. Riley Financial reiterated a “buy” rating on shares of Varex Imaging in a research note on Thursday, February 12th. Wall Street Zen cut Varex Imaging from a “buy” rating to a “hold” rating in a research note on Saturday, May 9th. Finally, Jefferies Financial Group reiterated a “hold” rating and issued a $14.50 price target on shares of Varex Imaging in a research note on Monday, February 2nd. One investment analyst has rated the stock with a Strong Buy rating, two have assigned a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $16.17.

Get Our Latest Stock Report on VREX

Insider Activity at Varex Imaging

In related news, Director Jay K. Kunkel sold 4,510 shares of the business’s stock in a transaction dated Friday, March 20th. The stock was sold at an average price of $11.14, for a total value of $50,241.40. Following the transaction, the director owned 23,450 shares in the company, valued at approximately $261,233. The trade was a 16.13% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Company insiders own 4.60% of the company’s stock.

About Varex Imaging

(Free Report)

Varex Imaging Corporation is a global provider of X-ray imaging components and solutions for the medical, security and industrial markets. The company designs, develops and manufactures a broad range of products that convert X-ray energy into high-resolution digital images. Its portfolio includes X-ray tubes, flat panel detectors, digital sensors, specialty radiographic tubes and related software, all engineered to meet the demanding requirements of original equipment manufacturers (OEMs) in diagnostic imaging, computed tomography (CT), fluoroscopy, mammography, dental radiography and non-destructive testing applications.

The company’s medical imaging offerings support a wide spectrum of clinical modalities, from portable radiography systems to advanced CT scanners, enhancing image quality and dose efficiency for healthcare providers.

See Also

Want to see what other hedge funds are holding VREX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Varex Imaging (NASDAQ:VREXFree Report).

Institutional Ownership by Quarter for Varex Imaging (NASDAQ:VREX)

Receive News & Ratings for Varex Imaging Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Varex Imaging and related companies with MarketBeat.com's FREE daily email newsletter.